NO303713B1 - Anvendelse av lacidipin for behandling av arteriosklerose - Google Patents

Anvendelse av lacidipin for behandling av arteriosklerose

Info

Publication number
NO303713B1
NO303713B1 NO932874A NO932874A NO303713B1 NO 303713 B1 NO303713 B1 NO 303713B1 NO 932874 A NO932874 A NO 932874A NO 932874 A NO932874 A NO 932874A NO 303713 B1 NO303713 B1 NO 303713B1
Authority
NO
Norway
Prior art keywords
lacidipine
arteriosclerosis
treatment
pyridinedicarboyxlic
dimethylethoxy
Prior art date
Application number
NO932874A
Other languages
English (en)
Norwegian (no)
Other versions
NO932874L (no
NO932874D0 (no
Inventor
Giovanni Gaviraghi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of NO932874L publication Critical patent/NO932874L/no
Publication of NO932874D0 publication Critical patent/NO932874D0/no
Publication of NO303713B1 publication Critical patent/NO303713B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO932874A 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose NO303713B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici
PCT/EP1992/000276 WO1992014460A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis

Publications (3)

Publication Number Publication Date
NO932874L NO932874L (no) 1993-08-12
NO932874D0 NO932874D0 (no) 1993-08-12
NO303713B1 true NO303713B1 (no) 1998-08-24

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932874A NO303713B1 (no) 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose

Country Status (24)

Country Link
US (1) US5455257A (ja)
EP (2) EP0576433A1 (ja)
JP (1) JP2996725B2 (ja)
KR (1) KR100188171B1 (ja)
AT (1) ATE157004T1 (ja)
AU (1) AU646929B2 (ja)
CA (1) CA2103805C (ja)
CZ (1) CZ281760B6 (ja)
DE (1) DE69221649T2 (ja)
DK (1) DK0499920T3 (ja)
ES (1) ES2106098T3 (ja)
GR (1) GR3024661T3 (ja)
HK (1) HK1009585A1 (ja)
IE (1) IE920453A1 (ja)
IL (1) IL100928A (ja)
IT (1) IT1244728B (ja)
MX (1) MX9200600A (ja)
NO (1) NO303713B1 (ja)
PH (1) PH30130A (ja)
RU (1) RU2136279C1 (ja)
SG (1) SG59972A1 (ja)
UA (1) UA27780C2 (ja)
WO (1) WO1992014460A1 (ja)
ZA (1) ZA921006B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868577A4 (en) * 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
AU646929B2 (en) 1994-03-10
CA2103805A1 (en) 1992-08-14
GR3024661T3 (en) 1997-12-31
DE69221649T2 (de) 1997-12-11
IE920453A1 (en) 1992-08-12
SG59972A1 (en) 1999-02-22
KR100188171B1 (en) 1999-06-01
ATE157004T1 (de) 1997-09-15
IL100928A (en) 1997-02-18
IT1244728B (it) 1994-08-08
ITMI910359A0 (it) 1991-02-13
RU2136279C1 (ru) 1999-09-10
US5455257A (en) 1995-10-03
CA2103805C (en) 2002-09-17
NO932874L (no) 1993-08-12
DK0499920T3 (da) 1998-01-26
NO932874D0 (no) 1993-08-12
JPH06505002A (ja) 1994-06-09
DE69221649D1 (de) 1997-09-25
WO1992014460A1 (en) 1992-09-03
UA27780C2 (uk) 2000-10-16
EP0499920B1 (en) 1997-08-20
AU1223192A (en) 1992-09-15
CZ165093A3 (en) 1994-03-16
CZ281760B6 (cs) 1997-01-15
PH30130A (en) 1997-01-21
ZA921006B (en) 1992-12-30
MX9200600A (es) 1992-10-30
ES2106098T3 (es) 1997-11-01
ITMI910359A1 (it) 1992-08-13
EP0576433A1 (en) 1994-01-05
HK1009585A1 (en) 1999-06-04
EP0499920A1 (en) 1992-08-26
JP2996725B2 (ja) 2000-01-11

Similar Documents

Publication Publication Date Title
DE69620306D1 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
NO914117D0 (no) Fungicide oxazolidinoner
ATE121295T1 (de) Augentropfenarzneimittel.
FI935777A (fi) AIDSin hoitamisessa käyttökelpoiset HIV-proteaasin inhibiittorit
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69019019T2 (de) 2,2,4-trisubstituierte tetrahydropyranische Ester und organoleptische Verwendung davon.
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
NO303713B1 (no) Anvendelse av lacidipin for behandling av arteriosklerose
EE200000290A (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
DE69231883D1 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
RU93054780A (ru) Применение лацидипина для лечения артериосклероза
DE69625069D1 (de) Insektizide von n-(substituiertes arylmethyl)-4-(bis (substituiertes phenyl oder pyridyl)methyl)-piperidin.
ITRM910211A0 (it) Impianto dentale endosseo.
NO953322D0 (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO178093C (no) Anordning for bedring av miljö i munnhulen ved tannbehandling
DZ1831A1 (fr) Isopropyl 2-méthoxyéthyl 4-(2-chloro-3-cyano-phényl)-1,4-dihydro 2,6-diméthyl-pyridine 3,5-dicarboxylate.
DE69616484D1 (de) Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel
DE69200943T2 (de) Derivate von Piperidin.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees